Chemistry: molecular biology and microbiology – Vector – per se
Reexamination Certificate
2005-01-04
2005-01-04
Guzo, David (Department: 1636)
Chemistry: molecular biology and microbiology
Vector, per se
C435S456000
Reexamination Certificate
active
06838280
ABSTRACT:
The present invention provides a retroviral vector containing an iduronate-2-sulfatase (IDS) gene but without selective marker gene, constructed on, as a backbone, a minimum sized MLV-based retroviral vector which does not contain any viral coding sequences but can still produce a high viral titer and drive a high level of gene expression.
REFERENCES:
Romano et al. Latest developments in gene transfer technology: Achievements, perspectives, and controversies over therapeutic applications. Stem cells 18:19-39, 2000.*
McIvor, R.S. Gene therapy of genetic diseases and cancer. Pediatr. Transplantation. vol. 3, suppl. 1, pp. 116-121, 1999.*
Dang et al. Gene therapy and transiational cancer research. Clin. Cancer Res. 5:471-474, 1999.*
Kim et al. Construction of retroviral vectors with improved safety, gene expression, and versatility. J. Virol. 72:994-1004, 1998.
Han Eun Young
Hong Youngtae
Kim Jong-Mook
Kim Sun-young
Yu Seung Shin
Anderson Kill & Olick PC
Guzo David
Nguyen Quang
ViroMed Limited
LandOfFree
Construction of high efficiency retroviral vector for gene... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Construction of high efficiency retroviral vector for gene..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Construction of high efficiency retroviral vector for gene... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3370068